The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Thin Film Drugs Market Research Report 2025
Synopsis
The global Oral Thin Film Drugs market was valued at US$ 1310.5 million in 2023 and is anticipated to reach US$ 2677.2 million by 2030, witnessing a CAGR of 10.9% during the forecast period 2024-2030.
North American market for Oral Thin Film Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oral Thin Film Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Oral Thin Film Drugs include Sumitomo Dainippon Pharma Co., Ltd., Pfizer, Novartis AG, ZIM Laboratories Limited, Indivior Plc., Allergan Plc., IntelGenx Corp, NAL Pharma and Wolters Kluwer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oral Thin Film Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Thin Film Drugs.
Report Scope
The Oral Thin Film Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Thin Film Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Thin Film Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sumitomo Dainippon Pharma Co., Ltd.
Pfizer
Novartis AG
ZIM Laboratories Limited
Indivior Plc.
Allergan Plc.
IntelGenx Corp
NAL Pharma
Wolters Kluwer
Segment by Type
Sublingual Film
Fully Dissolving Dental/Buccal Film
Segment by Application
Schizophrenia
Migraine
Opioid Dependence
Nausea & Vomiting
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Thin Film Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Thin Film Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Oral Thin Film Drugs market was valued at US$ 1310.5 million in 2023 and is anticipated to reach US$ 2677.2 million by 2030, witnessing a CAGR of 10.9% during the forecast period 2024-2030.
North American market for Oral Thin Film Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oral Thin Film Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Oral Thin Film Drugs include Sumitomo Dainippon Pharma Co., Ltd., Pfizer, Novartis AG, ZIM Laboratories Limited, Indivior Plc., Allergan Plc., IntelGenx Corp, NAL Pharma and Wolters Kluwer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oral Thin Film Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Thin Film Drugs.
Report Scope
The Oral Thin Film Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Thin Film Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Thin Film Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sumitomo Dainippon Pharma Co., Ltd.
Pfizer
Novartis AG
ZIM Laboratories Limited
Indivior Plc.
Allergan Plc.
IntelGenx Corp
NAL Pharma
Wolters Kluwer
Segment by Type
Sublingual Film
Fully Dissolving Dental/Buccal Film
Segment by Application
Schizophrenia
Migraine
Opioid Dependence
Nausea & Vomiting
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Thin Film Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Thin Film Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Oral Thin Film Drugs Market Overview
1.1 Product Overview and Scope of Oral Thin Film Drugs
1.2 Oral Thin Film Drugs Segment by Type
1.2.1 Global Oral Thin Film Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Sublingual Film
1.2.3 Fully Dissolving Dental/Buccal Film
1.3 Oral Thin Film Drugs Segment by Application
1.3.1 Global Oral Thin Film Drugs Market Value by Application: (2024-2030)
1.3.2 Schizophrenia
1.3.3 Migraine
1.3.4 Opioid Dependence
1.3.5 Nausea & Vomiting
1.3.6 Others
1.4 Global Oral Thin Film Drugs Market Size Estimates and Forecasts
1.4.1 Global Oral Thin Film Drugs Revenue 2019-2030
1.4.2 Global Oral Thin Film Drugs Sales 2019-2030
1.4.3 Global Oral Thin Film Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oral Thin Film Drugs Market Competition by Manufacturers
2.1 Global Oral Thin Film Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oral Thin Film Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oral Thin Film Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Oral Thin Film Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Thin Film Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Thin Film Drugs, Product Type & Application
2.7 Oral Thin Film Drugs Market Competitive Situation and Trends
2.7.1 Oral Thin Film Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Thin Film Drugs Players Market Share by Revenue
2.7.3 Global Oral Thin Film Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Thin Film Drugs Retrospective Market Scenario by Region
3.1 Global Oral Thin Film Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oral Thin Film Drugs Global Oral Thin Film Drugs Sales by Region: 2019-2030
3.2.1 Global Oral Thin Film Drugs Sales by Region: 2019-2024
3.2.2 Global Oral Thin Film Drugs Sales by Region: 2025-2030
3.3 Global Oral Thin Film Drugs Global Oral Thin Film Drugs Revenue by Region: 2019-2030
3.3.1 Global Oral Thin Film Drugs Revenue by Region: 2019-2024
3.3.2 Global Oral Thin Film Drugs Revenue by Region: 2025-2030
3.4 North America Oral Thin Film Drugs Market Facts & Figures by Country
3.4.1 North America Oral Thin Film Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oral Thin Film Drugs Sales by Country (2019-2030)
3.4.3 North America Oral Thin Film Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oral Thin Film Drugs Market Facts & Figures by Country
3.5.1 Europe Oral Thin Film Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oral Thin Film Drugs Sales by Country (2019-2030)
3.5.3 Europe Oral Thin Film Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Thin Film Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Thin Film Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oral Thin Film Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Oral Thin Film Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oral Thin Film Drugs Market Facts & Figures by Country
3.7.1 Latin America Oral Thin Film Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oral Thin Film Drugs Sales by Country (2019-2030)
3.7.3 Latin America Oral Thin Film Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Thin Film Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Thin Film Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oral Thin Film Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oral Thin Film Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Oral Thin Film Drugs Sales by Type (2019-2030)
4.1.1 Global Oral Thin Film Drugs Sales by Type (2019-2024)
4.1.2 Global Oral Thin Film Drugs Sales by Type (2025-2030)
4.1.3 Global Oral Thin Film Drugs Sales Market Share by Type (2019-2030)
4.2 Global Oral Thin Film Drugs Revenue by Type (2019-2030)
4.2.1 Global Oral Thin Film Drugs Revenue by Type (2019-2024)
4.2.2 Global Oral Thin Film Drugs Revenue by Type (2025-2030)
4.2.3 Global Oral Thin Film Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Oral Thin Film Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oral Thin Film Drugs Sales by Application (2019-2030)
5.1.1 Global Oral Thin Film Drugs Sales by Application (2019-2024)
5.1.2 Global Oral Thin Film Drugs Sales by Application (2025-2030)
5.1.3 Global Oral Thin Film Drugs Sales Market Share by Application (2019-2030)
5.2 Global Oral Thin Film Drugs Revenue by Application (2019-2030)
5.2.1 Global Oral Thin Film Drugs Revenue by Application (2019-2024)
5.2.2 Global Oral Thin Film Drugs Revenue by Application (2025-2030)
5.2.3 Global Oral Thin Film Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Oral Thin Film Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sumitomo Dainippon Pharma Co., Ltd.
6.1.1 Sumitomo Dainippon Pharma Co., Ltd. Corporation Information
6.1.2 Sumitomo Dainippon Pharma Co., Ltd. Description and Business Overview
6.1.3 Sumitomo Dainippon Pharma Co., Ltd. Oral Thin Film Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sumitomo Dainippon Pharma Co., Ltd. Oral Thin Film Drugs Product Portfolio
6.1.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Oral Thin Film Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Oral Thin Film Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Novartis AG
6.3.1 Novartis AG Corporation Information
6.3.2 Novartis AG Description and Business Overview
6.3.3 Novartis AG Oral Thin Film Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis AG Oral Thin Film Drugs Product Portfolio
6.3.5 Novartis AG Recent Developments/Updates
6.4 ZIM Laboratories Limited
6.4.1 ZIM Laboratories Limited Corporation Information
6.4.2 ZIM Laboratories Limited Description and Business Overview
6.4.3 ZIM Laboratories Limited Oral Thin Film Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ZIM Laboratories Limited Oral Thin Film Drugs Product Portfolio
6.4.5 ZIM Laboratories Limited Recent Developments/Updates
6.5 Indivior Plc.
6.5.1 Indivior Plc. Corporation Information
6.5.2 Indivior Plc. Description and Business Overview
6.5.3 Indivior Plc. Oral Thin Film Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Indivior Plc. Oral Thin Film Drugs Product Portfolio
6.5.5 Indivior Plc. Recent Developments/Updates
6.6 Allergan Plc.
6.6.1 Allergan Plc. Corporation Information
6.6.2 Allergan Plc. Description and Business Overview
6.6.3 Allergan Plc. Oral Thin Film Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Allergan Plc. Oral Thin Film Drugs Product Portfolio
6.6.5 Allergan Plc. Recent Developments/Updates
6.7 IntelGenx Corp
6.6.1 IntelGenx Corp Corporation Information
6.6.2 IntelGenx Corp Description and Business Overview
6.6.3 IntelGenx Corp Oral Thin Film Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 IntelGenx Corp Oral Thin Film Drugs Product Portfolio
6.7.5 IntelGenx Corp Recent Developments/Updates
6.8 NAL Pharma
6.8.1 NAL Pharma Corporation Information
6.8.2 NAL Pharma Description and Business Overview
6.8.3 NAL Pharma Oral Thin Film Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 NAL Pharma Oral Thin Film Drugs Product Portfolio
6.8.5 NAL Pharma Recent Developments/Updates
6.9 Wolters Kluwer
6.9.1 Wolters Kluwer Corporation Information
6.9.2 Wolters Kluwer Description and Business Overview
6.9.3 Wolters Kluwer Oral Thin Film Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Wolters Kluwer Oral Thin Film Drugs Product Portfolio
6.9.5 Wolters Kluwer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Thin Film Drugs Industry Chain Analysis
7.2 Oral Thin Film Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Thin Film Drugs Production Mode & Process
7.4 Oral Thin Film Drugs Sales and Marketing
7.4.1 Oral Thin Film Drugs Sales Channels
7.4.2 Oral Thin Film Drugs Distributors
7.5 Oral Thin Film Drugs Customers
8 Oral Thin Film Drugs Market Dynamics
8.1 Oral Thin Film Drugs Industry Trends
8.2 Oral Thin Film Drugs Market Drivers
8.3 Oral Thin Film Drugs Market Challenges
8.4 Oral Thin Film Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
